Woodhaven Health & Rehab: Missed Cancer Treatment - PA
The resident needed Faslodex, an injection used to treat certain hormone receptor-positive breast cancers. The drug is typically administered on a schedule, monthly or more frequently depending on the treatment plan. Missing doses is not a minor inconvenience. The injections are the treatment.
The first appointment on record went wrong on June 5, when a bone density scan, a DXA, was cancelled. Three weeks later, on June 26, the resident was a no-show for a Faslodex appointment and labs. The facility did not transport them. On July 3, the Faslodex injection was cancelled. On July 10, cancelled again. July 31, another no-show. August 7, cancelled. August 7 was not the end. There was one more no-show after that.
Seven missed appointments across roughly ten weeks. A bone scan that never happened. Blood work that was skipped. Injections that the resident's physician had ordered and that the facility failed, repeatedly, to arrange.
The inspection report does not say whether anyone at Woodhaven noticed the pattern building. It does not say whether a nurse flagged it, whether a family member called, whether anyone reviewed the appointment log and asked why the same resident kept missing the same treatment. What it says is that by the time inspectors arrived on September 3, the failures had accumulated across three calendar months without resolution.
The nursing home administrator, interviewed at approximately noon that day, confirmed it. The facility had failed to schedule the ordered appointments. The facility had failed to provide transportation. The administrator did not dispute this. The inspection report records the confirmation plainly, without elaboration.
The finding covered one resident out of three whose records were reviewed. That means two residents' outside appointment needs were apparently being met. For this one resident, they were not.
What the inspection does not contain is also worth noting. There is no indication that the facility notified the ordering physician each time an appointment was missed. There is no documentation cited of any internal review, any corrective action taken mid-pattern, any conversation with the resident or their family about why the treatment kept falling through. The report does not say those things happened. It also does not say they did not. What it records is the outcome: a resident went without ordered cancer treatment for months while living in a facility whose job it was to make sure that did not happen.
Faslodex is not a medication a nurse administers in a hallway. It requires an outside appointment, a provider, a facility equipped to give the injection. That means the nursing home has to do something: schedule the appointment, arrange a ride, confirm the date, get the resident there. Each of the seven missed appointments represents a moment when that chain broke. The inspection report does not say where in the chain it broke each time, whether the appointments were cancelled by the outside provider and never rescheduled, or whether the facility simply failed to book transportation, or both. The administrator's confirmation that the facility failed to schedule and failed to transport suggests the failures were internal.
Pennsylvania's Department of Health cited Woodhaven under six separate regulatory codes, covering the responsibilities of the licensee, management, resident rights, physician services, social services, and nursing services. The breadth of the citation list reflects what the facts suggest: this was not one department's failure. Scheduling, nursing, administration, and social services all have roles in getting a resident to a medical appointment. All of them, in this case, did not perform those roles for this resident, for this treatment, across this stretch of time.
The inspection classified the harm level as minimal harm or potential for actual harm. That classification reflects the regulatory framework's language, not a clinical assessment of what months of missed Faslodex doses mean for a patient whose physician ordered them.
The resident is still at Woodhaven. The inspection report does not say whether the appointments have since been scheduled.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Woodhaven Health & Rehab Center from 2025-09-03 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: September 26, 2026 · Our methodology
WOODHAVEN HEALTH & REHAB CENTER in MONROEVILLE, PA was cited for violations during a health inspection on September 3, 2025.
The resident needed Faslodex, an injection used to treat certain hormone receptor-positive breast cancers.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.